AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 22578110 — intervention group
Group type: EXPERIMENTAL
Intervention: NSAID (rofecoxib 50 mg)
Number of subjects: 22
Study 22578110 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study 20947859 — intervention group
Group type: EXPERIMENTAL
Intervention: Granulocyte colony-stimulating factor (G-CSF) at doses of 30-180 μg/kg over 3 days
Number of subjects: 44
Study 20947859 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study 20947859 — intervention group
Group type: EXPERIMENTAL
Intervention: Granulocyte colony-stimulating factor (G-CSF)
Number of subjects: 44
Study 18958985 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational interviewing (MI)
Number of subjects: 33
Study 18958985 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 33
Study 16900709 — intervention group
Group type: EXPERIMENTAL
Intervention: Nephrostomy tube (NT) and temporary ureteral catheter (TU) in group A
Number of subjects: 60
Study 16900709 — intervention group
Group type: COMPARATOR
Intervention: Only temporary ureteral catheter (TU) in group B
Number of subjects: 60
Study 16900709 — intervention group
Group type: COMPARATOR
Intervention: Only indwelling ureteral catheter (IU) in group C
Number of subjects: 60
Study 14712889 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical brimonidine 0.2% b.d. (n = 90)
Number of subjects: 272
Study 14712889 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical dorzolamide 2% b.d. (n=91)
Number of subjects: 272
Study 14712889 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical latanoprost 0.005% o.d. (n = 91)
Number of subjects: 272
Study 14712889 — intervention group
Group type: COMPARATOR
Intervention: Intergroup comparison of efficacy between brimonidine and dorzolamide
Number of subjects: 272
Study 14712889 — intervention group
Group type: COMPARATOR
Intervention: Intergroup comparison of efficacy between dorzolamide and latanoprost
Number of subjects: 272
Study 14712889 — intervention group
Group type: COMPARATOR
Intervention: Intergroup comparison of efficacy between brimonidine and latanoprost
Number of subjects: 272
Study 10826223 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine
Number of subjects: 0
Study 10826223 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 0
Study 8877678 — intervention group
Group type: EXPERIMENTAL
Intervention: One transdermal delivery system
Number of subjects: 12
Study 8877678 — intervention group
Group type: EXPERIMENTAL
Intervention: Two transdermal delivery systems
Number of subjects: 12
Study 8877678 — intervention group
Group type: EXPERIMENTAL
Intervention: Three transdermal delivery systems
Number of subjects: 12
Study 8877678 — intervention group
Group type: EXPERIMENTAL
Intervention: Two to three transdermal delivery systems
Number of subjects: 12
Study 8877678 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard recommended dose of two transdermal delivery systems
Number of subjects: 12
Study 1643987 — intervention group
Group type: EXPERIMENTAL
Intervention: Breast preservation therapy
Number of subjects: 1119
Study 6084978 — intervention group
Group type: EXPERIMENTAL
Intervention: Pygeum africanum extract
Number of subjects: 120
Study 6084978 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study 30022595 — intervention group
Group type: EXPERIMENTAL
Intervention: Botanical face cleanser with hops and willow bark extract and disodium cocoyl glutamate
Number of subjects: 21
Study 30022595 — intervention group
Group type: COMPARATOR
Intervention: Standard face cleanser with sodium laureth sulfate (SLES)
Number of subjects: 21
Study 30022595 — intervention group
Group type: EXPERIMENTAL
Intervention: Both cleansers
Number of subjects: 21
Study 27554662 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose CT (120 kVp, 45 mAs)
Number of subjects: 135
Study 27554662 — intervention group
Group type: COMPARATOR
Intervention: Standard-dose CT (120 kVp, 100 mAs)
Number of subjects: 135
Study 25856525 — intervention group
Group type: EXPERIMENTAL
Intervention: Phonological awareness training
Number of subjects: 30
Study 25856525 — intervention group
Group type: EXPERIMENTAL
Intervention: Visually-based reading training (repeated reading of sight words)
Number of subjects: 30
Study 25856525 — intervention group
Group type: EXPERIMENTAL
Intervention: Phonology-based reading training (phonics instruction)
Number of subjects: 30
Study 25856525 — intervention group
Group type: COMPARATOR
Intervention: Control group (typical readers)
Number of subjects: 30
Study 24497655 — intervention group
Group type: EXPERIMENTAL
Intervention: Adenotonsillectomy (AT)
Number of subjects: 464
Study 24497655 — intervention group
Group type: COMPARATOR
Intervention: Medical management
Number of subjects: 464
Study 22927772 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacogenetic-based warfarin dosing algorithm (based on CYP2C9 and VKORC1 genotypes)
Number of subjects: 101
Study 22927772 — intervention group
Group type: COMPARATOR
Intervention: Control group (2.5mg/d for 3 days, then adjusted to INR)
Number of subjects: 101
Study 19589291 — intervention group
Group type: EXPERIMENTAL
Intervention: Melatonin and Sulodexide
Number of subjects: 102
Study 19589291 — intervention group
Group type: EXPERIMENTAL
Intervention: Melatonin alone
Number of subjects: 102
Study 19589291 — intervention group
Group type: COMPARATOR
Intervention: Control group (no therapy)
Number of subjects: 102
Study 18076560 — intervention group
Group type: EXPERIMENTAL
Intervention: Insecticide-treated net (ITN) use
Number of subjects: 685
Study 18076560 — intervention group
Group type: EXPERIMENTAL
Intervention: Malaria parasitaemia
Number of subjects: 685
Study 18076560 — intervention group
Group type: EXPERIMENTAL
Intervention: Any anaemia (haemoglobin < 11 g/dl)
Number of subjects: 685
Study 18076560 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate anaemia (haemoglobin < 8 g/dl)
Number of subjects: 685
Study 18076560 — intervention group
Group type: EXPERIMENTAL
Intervention: Demographic and medical factors
Number of subjects: 685
Study 18076560 — intervention group
Group type: EXPERIMENTAL
Intervention: Hospitalization due to malaria
Number of subjects: 685
Study 12750107 — intervention group
Group type: EXPERIMENTAL
Intervention: Superior-hinge flap
Number of subjects: 52
Study 12750107 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal-hinge flap
Number of subjects: 52
Study 11090714 — intervention group
Group type: EXPERIMENTAL
Intervention: dTpa
Number of subjects: 548
Study 11090714 — intervention group
Group type: EXPERIMENTAL
Intervention: pa
Number of subjects: 548
Study 11090714 — intervention group
Group type: COMPARATOR
Intervention: Td
Number of subjects: 548
Study 11090714 — intervention group
Group type: EXPERIMENTAL
Intervention: dTpa and pa
Number of subjects: 548
Study 11090714 — intervention group
Group type: EXPERIMENTAL
Intervention: dTpa and Td
Number of subjects: 548
Study 9065681 — intervention group
Group type: EXPERIMENTAL
Intervention: Paroxetine
Number of subjects: 176
Study 9065681 — intervention group
Group type: EXPERIMENTAL
Intervention: Clomipramine
Number of subjects: 176
Study 9065681 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 176
Study 8103876 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucose-based ORS solution
Number of subjects: 460
Study 3713254 — intervention group
Group type: EXPERIMENTAL
Intervention: 360 mg Mg/day (as magnesium citrate tablets)
Number of subjects: 35
Study 3713254 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study 30212930 — intervention group
Group type: EXPERIMENTAL
Intervention: Nocturnal hemodialysis (NHD)
Number of subjects: 0
Study 27494036 — intervention group
Group type: EXPERIMENTAL
Intervention: Sequential arm (SA): induction cisplatin-5fluorouracil followed by 70Gy-RT for responders or total laryngectomy and post-operative RT for non-responders
Number of subjects: 450
Study 27494036 — intervention group
Group type: COMPARATOR
Intervention: Alternating arm (AA): cisplatin-5fluorouracil alternated with three 2-week courses of 20Gy-RT for a total dose of 60Gy
Number of subjects: 450
Study 24608204 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified inferior alveolar nerve block technique
Number of subjects: 109
Study 24608204 — intervention group
Group type: COMPARATOR
Intervention: Conventional Halsted technique
Number of subjects: 109
Study 23069788 — intervention group
Group type: EXPERIMENTAL
Intervention: Criterion-based training on the Endoscopic Sinus Surgery Simulator
Number of subjects: 14
Study 23069788 — intervention group
Group type: COMPARATOR
Intervention: Control subjects repeated the surgical procedure twice
Number of subjects: 14
Study 23069788 — intervention group
Group type: COMPARATOR
Intervention: Attending surgeons
Number of subjects: 14
Study 23069788 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental subjects
Number of subjects: 14
Study 20478035 — intervention group
Group type: EXPERIMENTAL
Intervention: Case management (telephone monitoring and home visits)
Number of subjects: 199
Study 20478035 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 199
Study 18765484 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg/day of aripiprazole
Number of subjects: 302
Study 18765484 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mg/day of aripiprazole
Number of subjects: 302
Study 18765484 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 302
Study 15759246 — intervention group
Group type: EXPERIMENTAL
Intervention: Goniometric STCA measurements
Number of subjects: 18
Study 15759246 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual STCA measurements
Number of subjects: 18
Study 15759246 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual STCA and goniometric STCA
Number of subjects: 18
Study 12909392 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine (0.5 mg/kg)
Number of subjects: 12
Study 12909392 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 12
Study 11198392 — intervention group
Group type: EXPERIMENTAL
Intervention: Circular stapled procedure
Number of subjects: 40
Study 11198392 — intervention group
Group type: COMPARATOR
Intervention: Milligan‐Morgan haemorrhoidectomy
Number of subjects: 40
Study 11198392 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 40
Study 8867350 — intervention group
Group type: EXPERIMENTAL
Intervention: PTFE
Number of subjects: 250
Study 8867350 — intervention group
Group type: EXPERIMENTAL
Intervention: Dacron
Number of subjects: 250
Study 1858191 — intervention group
Group type: EXPERIMENTAL
Intervention: Automatic blood-pressure registration on a computerized ergometer cycle
Number of subjects: 50
Study 1858191 — intervention group
Group type: COMPARATOR
Intervention: Manual blood-pressure registration using a standard mercury sphygmomanometer
Number of subjects: 50
Study 6357339 — intervention group
Group type: EXPERIMENTAL
Intervention: Proximal gastric vagotomy (PGV)
Number of subjects: 145
Study 6357339 — intervention group
Group type: COMPARATOR
Intervention: Truncal vagotomy with antrectomy (TVA)
Number of subjects: 145
Study 31075675 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual Reality Exposure Therapy (VRET)
Number of subjects: 100
Study 31075675 — intervention group
Group type: COMPARATOR
Intervention: In-vivo One-Session Treatment (OST)
Number of subjects: 100
Study 29606861 — intervention group
Group type: EXPERIMENTAL
Intervention: GFF MDI 14.4/10 μg
Number of subjects: 292
Study 29606861 — intervention group
Group type: COMPARATOR
Intervention: GP MDI 14.4 μg
Number of subjects: 292
Study 29606861 — intervention group
Group type: COMPARATOR
Intervention: FF MDI 10 μg
Number of subjects: 292
Study 27913559 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 year of supervised, centre-based heavy resistance training
Number of subjects: 450
Study 27913559 — intervention group
Group type: EXPERIMENTAL
Intervention: home-based moderate intensity resistance training
Number of subjects: 450
Study 27913559 — intervention group
Group type: COMPARATOR
Intervention: habitual physical activity (control)
Number of subjects: 450
Study 25083017 — intervention group
Group type: EXPERIMENTAL
Intervention: Three nights of portable sleep monitoring (3N-PM)
Number of subjects: 56
Study 25083017 — intervention group
Group type: COMPARATOR
Intervention: Polysomnography (PSG)
Number of subjects: 56
Study 22790008 — intervention group
Group type: EXPERIMENTAL
Intervention: i.v. ketamine (bolus at induction, continuous infusion during surgery and first 48 hours postoperatively)
Number of subjects: 60
Study 22790008 — intervention group
Group type: EXPERIMENTAL
Intervention: i.v. ketamine
Number of subjects: 60
Study 22790008 — intervention group
Group type: COMPARATOR
Intervention: i.v. placebo (saline solution under the same infusion modalities)
Number of subjects: 60
Study 22790008 — intervention group
Group type: COMPARATOR
Intervention: i.v. placebo
Number of subjects: 60
Study 20307799 — intervention group
Group type: EXPERIMENTAL
Intervention: Buprenorphine-naloxone for short-term opioid detoxification
Number of subjects: 0
Study 20307799 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 17359515 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile phone RF exposure
Number of subjects: 17
Study 17359515 — intervention group
Group type: COMPARATOR
Intervention: Sham RF exposure
Number of subjects: 17
Study 16283835 — intervention group
Group type: EXPERIMENTAL
Intervention: Adherence enhancement program
Number of subjects: 85
Study 16283835 — intervention group
Group type: COMPARATOR
Intervention: Comparison group
Number of subjects: 85
Study 12040967 — intervention group
Group type: EXPERIMENTAL
Intervention: Pitavastatin 1 mg/day or more
Number of subjects: 0
Study 12040967 — intervention group
Group type: EXPERIMENTAL
Intervention: Pitavastatin 1 mg/day to 4 mg/day
Number of subjects: 0
Study 12040967 — intervention group
Group type: EXPERIMENTAL
Intervention: Pitavastatin
Number of subjects: 0
Study 12799977 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-energy shock-wave therapy (3000 impulses of 0.08 mJ/mm(2))
Number of subjects: 2
Study 12799977 — intervention group
Group type: COMPARATOR
Intervention: Control group (30 impulses of 0.08 mJ/mm(2))
Number of subjects: 2
Study 7622270 — intervention group
Group type: EXPERIMENTAL
Intervention: Acidic syndet bar
Number of subjects: 120
Study 7622270 — intervention group
Group type: COMPARATOR
Intervention: Conventional soap bar
Number of subjects: 120
Study 1699337 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulmonary tuberculosis patients
Number of subjects: 65
Study 1699337 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment for pulmonary tuberculosis
Number of subjects: 65
Study 1699337 — intervention group
Group type: EXPERIMENTAL
Intervention: Kuwaiti environment exposure
Number of subjects: 65
Study 6451422 — intervention group
Group type: EXPERIMENTAL
Intervention: Anticholinergic drugs
Number of subjects: 35
Study 6451422 — intervention group
Group type: EXPERIMENTAL
Intervention: Mast-cell stabilizing cromoglycate
Number of subjects: 35
Study 6451422 — intervention group
Group type: EXPERIMENTAL
Intervention: beta 2-Sympathomimetic drugs
Number of subjects: 35
Study 30968326 — intervention group
Group type: EXPERIMENTAL
Intervention: LM-Supreme™ (LM-S)
Number of subjects: 100
Study 30968326 — intervention group
Group type: COMPARATOR
Intervention: Endotracheal tube (ETT)
Number of subjects: 100
Study 31040642 — intervention group
Group type: EXPERIMENTAL
Intervention: Choline alfoscerate tablet (1,200 mg, 400 mg × three doses)
Number of subjects: 50
Study 31040642 — intervention group
Group type: COMPARATOR
Intervention: Soft gelatin capsule (Gliatilin®) (1,200 mg, 400 mg × three doses)
Number of subjects: 50
Study 31040642 — intervention group
Group type: COMPARATOR
Intervention: Choline alfoscerate tablet vs Soft gelatin capsule
Number of subjects: 50
Study 28472284 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual-based behavioral intervention
Number of subjects: 688
Study 28472284 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 688
Study 25748830 — intervention group
Group type: EXPERIMENTAL
Intervention: Egg breakfast
Number of subjects: 0
Study 25748830 — intervention group
Group type: COMPARATOR
Intervention: Bagel breakfast
Number of subjects: 0
Study 25074771 — intervention group
Group type: EXPERIMENTAL
Intervention: Lutein 20 mg/d
Number of subjects: 39
Study 25074771 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study 25074771 — intervention group
Group type: EXPERIMENTAL
Intervention: Lutein 20 mg/d (in patients with low plasma lutein)
Number of subjects: 39
Study 25074771 — intervention group
Group type: COMPARATOR
Intervention: Placebo (in patients with low plasma lutein)
Number of subjects: 39
Study 23182475 — intervention group
Group type: EXPERIMENTAL
Intervention: Deslorelin acetate (100 μg IM every 12h)
Number of subjects: 56
Study 23182475 — intervention group
Group type: COMPARATOR
Intervention: Saline (control group)
Number of subjects: 56
Study 19762523 — intervention group
Group type: EXPERIMENTAL
Intervention: Specific strength training of the neck/shoulder muscles
Number of subjects: 42
Study 19762523 — intervention group
Group type: COMPARATOR
Intervention: General fitness training performed as leg-bicycling
Number of subjects: 42
Study 19762523 — intervention group
Group type: COMPARATOR
Intervention: Reference intervention without physical activity
Number of subjects: 42
Study 17520465 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciclopirox olamine (1.5%) shampoo
Number of subjects: 350
Study 17520465 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketoconazole (2.0%) shampoo
Number of subjects: 350
Study 17520465 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 350
Study 16818930 — intervention group
Group type: COMPARATOR
Intervention: Active treatment
Number of subjects: 0
Study 16818930 — intervention group
Group type: EXPERIMENTAL
Intervention: Not specified
Number of subjects: 0
Study 12560148 — intervention group
Group type: EXPERIMENTAL
Intervention: Preparation book for surgery (experimental group)
Number of subjects: 400
Study 12560148 — intervention group
Group type: COMPARATOR
Intervention: No preparation book (control group)
Number of subjects: 400
Study 10221357 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mg propranolol hydrochloride
Number of subjects: 36
Study 10221357 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mg nadolol
Number of subjects: 36
Study 10221357 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study 8730629 — intervention group
Group type: EXPERIMENTAL
Intervention: Corticosteroid + IUI (n = 18)
Number of subjects: 36
Study 8730629 — intervention group
Group type: COMPARATOR
Intervention: IUI alone (n = 18)
Number of subjects: 36
Study 1856403 — intervention group
Group type: EXPERIMENTAL
Intervention: Warfarin
Number of subjects: 378
Study 1856403 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 378
Study 6336708 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxycycline
Number of subjects: 145
Study 6336708 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 145
Study 30503232 — intervention group
Group type: EXPERIMENTAL
Intervention: Game-based intervention
Number of subjects: 14
Study 30503232 — intervention group
Group type: COMPARATOR
Intervention: Standard EMG training (MyoBoy)
Number of subjects: 14
Study 27247166 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided cannulation
Number of subjects: 106
Study 27247166 — intervention group
Group type: COMPARATOR
Intervention: Palpation technique
Number of subjects: 106
Study 27247166 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 106
Study 27347553 — intervention group
Group type: COMPARATOR
Intervention: Colgate Cavity Protection (1000 ppmF‐MFP)
Number of subjects: 71
Study 27347553 — intervention group
Group type: COMPARATOR
Intervention: Sensodyne Total Care (1000 ppmF‐NaF + 19300 ppmK(+)‐KNO3)
Number of subjects: 71
Study 27347553 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinpro Tooth Crème (950 ppmF‐NaF + fTCP)
Number of subjects: 71
Study 27347553 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinpro Tooth Crème (brushing + additional topical application)
Number of subjects: 71
Study 22930148 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose magnesium sulphate (9 g loading dose: 4 g iv and 5 g im; maintenance 2.5 g im every 4 hours for 24 hours)
Number of subjects: 72
Study 22930148 — intervention group
Group type: COMPARATOR
Intervention: Standard dose magnesium sulphate (14 g loading dose; maintenance 5 g im every 4 hours)
Number of subjects: 72
Study 20633669 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient education and supervised exercise (PE+SE)
Number of subjects: 109
Study 20633669 — intervention group
Group type: COMPARATOR
Intervention: Patient education alone (PE)
Number of subjects: 109
Study 18155339 — intervention group
Group type: EXPERIMENTAL
Intervention: Intention-to-reverse condition
Number of subjects: 0
Study 18155339 — intervention group
Group type: COMPARATOR
Intervention: Passive condition
Number of subjects: 0
Study 15942259 — intervention group
Group type: EXPERIMENTAL
Intervention: Estradiol (2 mg estradiol valerate)
Number of subjects: 51
Study 15942259 — intervention group
Group type: EXPERIMENTAL
Intervention: Estradiol plus progesterone (100 mg micronized progesterone)
Number of subjects: 51
Study 15942259 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 51
Study 12917302 — intervention group
Group type: EXPERIMENTAL
Intervention: Methotrexate (15 mg per week)
Number of subjects: 88
Study 12917302 — intervention group
Group type: COMPARATOR
Intervention: Cyclosporine (3 mg per kilogram of body weight per day)
Number of subjects: 88
Study 12917302 — intervention group
Group type: EXPERIMENTAL
Intervention: Methotrexate
Number of subjects: 88
Study 12917302 — intervention group
Group type: COMPARATOR
Intervention: Cyclosporine
Number of subjects: 88
Study 12917302 — intervention group
Group type: EXPERIMENTAL
Intervention: Methotrexate and Cyclosporine
Number of subjects: 88
Study 10566922 — intervention group
Group type: EXPERIMENTAL
Intervention: Tramadol
Number of subjects: 80
Study 10566922 — intervention group
Group type: COMPARATOR
Intervention: Morphine
Number of subjects: 80
Study 8762389 — intervention group
Group type: EXPERIMENTAL
Intervention: Personal health education given every four months
Number of subjects: 688
Study 8762389 — intervention group
Group type: COMPARATOR
Intervention: Control group (no education)
Number of subjects: 688
Study 1817625 — intervention group
Group type: EXPERIMENTAL
Intervention: Air
Number of subjects: 50
Study 1817625 — intervention group
Group type: COMPARATOR
Intervention: Saline
Number of subjects: 50
Study 6225508 — intervention group
Group type: EXPERIMENTAL
Intervention: Streptozotocin, mitomycin C, and 5‐FU (SMF)
Number of subjects: 116